CIK 0001723128 · Large accelerated filer
Amneal Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- Phone
- (908) 947-3120
- Former names
- Atlas Holdings, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-22 | Shah Nikita Executive Vice President | Sale | −114,492 | $9.66 | $1.1M | 152,743 |
| 2025-08-20 | BOYER ANDREW S Executive Vice President | Option exercise | +175,000 | $2.75 | $481K | 431,670 |
| 2025-08-20 | BOYER ANDREW S Executive Vice President | Sale | −279,244 | $9.38 | $2.6M | 152,426 |
| 2025-08-20 | BOYER ANDREW S Executive Vice President | Option exercise · Stock Option | −175,000 | 97,480 | ||
| 2025-08-15 | Konidaris Tasos Executive Vice President & CFO | Sale | −219,159 | $9.43 | $2.1M | 122,152 |
| 2025-08-14 | Shah Nikita Executive Vice President | Sale | −71,694 | $9.29 | $666K | 267,235 |
| 2025-08-14 | Konidaris Tasos Executive Vice President & CFO | Sale | −119,206 | $9.30 | $1.1M | 341,311 |
| 2025-08-13 | Konidaris Tasos Executive Vice President & CFO | Sale | −161,365 | $9.22 | $1.5M | 460,517 |
| 2025-08-12 | Shah Nikita Executive Vice President | Sale | −50,000 | $9.04 | $452K | 338,929 |
| 2025-08-12 | Daly Jason B. EVP, Chief Legal Officer | Sale | −22,000 | $9.05 | $199K | 10,606 |
| 2025-08-12 | BOYER ANDREW S Executive Vice President | Sale | −33,436 | $9.05 | $303K | 256,670 |
| 2025-06-16 | Patel Gautam Director | Sale 10b5-1 | −94,906 | $8.02 | $761K | 1,609,144 |
| 2025-06-10 | Patel Gautam Director | Sale | −56,426 | $8.02 | $453K | 1,704,050 |
| 2025-05-16 | Shah Nikita Executive Vice President | Sale | −49,140 | $7.58 | $372K | 388,929 |
| 2025-05-12 | Kiely John Director | Sale | −50,000 | $7.59 | $380K | 257,433 |
| 2025-05-06 | BUCHI J KEVIN Director | Grant or award · Restricted Stock Units | +34,819 | 34,819 | ||
| 2025-05-06 | Yanai Shlomo Director | Grant or award · Restricted Stock Units | +34,819 | 34,819 | ||
| 2025-05-06 | Autor Deborah M. Director | Grant or award · Restricted Stock Units | +34,819 | 34,819 | ||
| 2025-05-06 | Nark Ted C Director | Grant or award · Restricted Stock Units | +34,819 | 34,819 | ||
| 2025-05-06 | Kiely John Director | Grant or award · Restricted Stock Units | +34,819 | 34,819 |
Page 8 of 31 · 617 trades